Concepedia

Julian Levell

JL

Statistics

Publications

23

Citations

982

H-Index

18

Active since

1996

Affiliations

Constellation Pharmaceuticals (United States)(Current)

University of Florida

Novartis (United States)

Novartis (China)

Friedrich Schiller University Jena

Julian Levell is an author at Constellation Pharmaceuticals (United States) specializing in natural sciences, drug discovery, and medicine.

ORCID

Top concepts

Publications per year

1996–2024

23

Publications

23

Isocitrate Dehydrogenase (IDH) Mutations Promote a Reversible ZEB1/MicroRNA (miR)-200-dependent Epithelial-Mesenchymal Transition (EMT)

Alexandra Grassian, Fallon Lin, Rosemary Barrett et al. · Journal of Biological Chemistry · 2012 · 136 citations · Full text

Discovery and Evaluation of Clinical Candidate IDH305, a Brain Penetrant Mutant IDH1 Inhibitor

Young Shin Cho, Julian Levell, Gang Liu et al. · ACS Medicinal Chemistry Letters · 2017 · 113 citations · Full text

New hypotheses about the structure–function of proprotein convertase subtilisin/kexin type 9: Analysis of the epidermal growth factor‐like repeat A docking site using WaterMap

Robert A. Pearlstein, Qiying Hu, Jing Zhou et al. · Proteins Structure Function and Bioinformatics · 2010 · 78 citations

, , +15

Discovery of CPI-1612: A Potent, Selective, and Orally Bioavailable EP300/CBP Histone Acetyltransferase Inhibitor

Jonathan E. Wilson, Gaurav Patel, Chirag Patel et al. · ACS Medicinal Chemistry Letters · 2020 · 74 citations · Full text

Allosteric Mutant IDH1 Inhibitors Reveal Mechanisms for IDH1 Mutant and Isoform Selectivity

Xiaoling Xie, Daniel Baird, Kimberly Elizabeth Bowen et al. · Structure · 2017 · 66 citations

, , +7

1–5 of 23